Abstract
Background: The characteristics of patients with bronchiectasis in Australia have not been well described. Through recruitment to the Australian Bronchiectasis Registry (ABR), we recently described the characteristics of a cohort from two tertiary centres in Sydney.
Aim: To compare the characteristics and patterns of care in cohorts from three tertiary bronchiectasis centres in Sydney, Milan and Dundee.
Methods: 270 eligible patients (bronchiectasis on CT, symptoms, no CF) were recruited to the ABR from 2 tertiary centres in Sydney. Sydney patients were compared with patients enrolled in EMBARC from Milan, Italy (N=452) and Dundee, UK (N=362).
Results: The Australian cohort was younger, more likely to be female with lower severity of illness and exacerbations, but higher sputum volume. A summary of key characteristics is shown in table 1.
*p<0.05 (ANOVA)
Conclusions: The Sydney cohort had milder disease with less exacerbations but more hospitalisations, suggestive of poorer access to and uptake of home intravenous therapy. Despite the higher prevalence of chronic P. aeruginosa in the Milan cohort, macrolides and nebulised antibiotics were used more frequently in the Sydney and Dundee cohorts.
Footnotes
Cite this article as: European Respiratory Journal 2018 52: Suppl. 62, PA352.
This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).
- Copyright ©the authors 2018